Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

NCT01827618 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Invasive Bladder Cancer Stage II

Interventions

DRUG: Rapamycin

Sponsor

The University of Texas Health Science Center at San Antonio